SUPN Overview

Company Profile

Related stocks

LQDA • United States

Liquidia Corporation

27.38 USD

2.45B USD 1Y +16.4%

BCRX • United States

BioCryst Pharmaceuticals, Inc.

8.55 USD

2.18B USD 1Y +13.9%

PBH • United States

Prestige Consumer Healthcare In

48.23 USD

2.28B USD 1Y -24.4%

ANIP • United States

ANI Pharmaceuticals, Inc.

73.89 USD

1.7B USD 1Y -21.5%

PAHC • United States

Phibro Animal Health Corporatio

38.3 USD

1.56B USD 1Y +0.8%

XERS • United States

Xeris Biopharma Holdings, Inc.

10.48 USD

1.91B USD 1Y +24.3%

ETON • United States

Eton Pharmaceuticals, Inc.

55.21 USD

1.58B USD 1Y +161.6%

PCRX • United States

Pacira BioSciences, Inc.

36.31 USD

1.45B USD 1Y +55.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

United States

Region

North America

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

35.3% p.a.

Max Drawdown (5Y)

-45.9%

Sharpe Ratio (5Y)

0.21

Beta Factor

0.55

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (35.3% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -75.9% in the extended horizon.